Arizona State University
COVID-19 Pandemic Accelerated Development of CRISPR as a Diagnostic Platform in 2020
The pace of development for CRISPR-based infectious disease assays increased as the pandemic progress
ASU Team Wins $6M in Government Funding to Develop Rapid Saliva Testing System for Coronavirus
The test will be designed to run on a portable device that can ultimately be rolled out to point-of-need settings such as doctors' offices and workplaces.
Axim Aims to Commercialize Sapphire BioTech's Antibody-Based Cancer Assays as Companion Diagnostics
The firm expects to launch a tissue-based immunohistochemistry version of the test, which detects QSOX1, in mid-2021, followed by a dipstick plasma-based assay by early 2022.
Takara Bio, BioSyntagma Develop High-Throughput SARS-CoV-2 Detection Method
The new method uses Takara Bio's SmartChip PCR instrument, chips, and reagents to run 5,184 reactions per chip in less than 30 minutes.
A comprehensive study of genomics malpractice lawsuits showed only a modest increase in recent years, but ASU’s Marchant wouldn't bet on it staying this way in the long term.
Jan 15, 2018